Norway: Nordic Nanovector names Malene Brondberg interim CEO

Malene Brondberg, interim CEO, Nordic Nanovector

Nordic Nanovector, a biopharmaceutical company focused on haematological cancers, has appointed Malene Brondberg as interim CEO, replacing Peter Braun who leaves the position at the company for personal reasons. Brondberg will continue in her role as CFO. The Board has initiated a search for a new CEO. Brondberg joined Nordic Nanovector as VP of investor…

You must be a HMI Subscriber to view this content.

Subscribe Now »